SCHEMBL8669491

SCHEMBL8669491

CC(=O)Nc1ccc2c(c1)CC(C(C)C(=O)O)C2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.47
ADRA2A P08913 1/20 0.47
MAOA P21397 1/20 0.47
SLC6A2 P23975 1/20 0.47
HTR2C P28335 1/20 0.47
SLC6A4 P31645 1/20 0.47
HTR2B P41595 1/20 0.47
BAZ2B Q9UIF8 1/20 0.46
GRIA2 P42262 1/20 0.46
NPC1 O15118 8/20 0.44
RAB9A P51151 8/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 1/20 0.44
POLB P06746 3/20 0.43
NFKB1 P19838 2/20 0.43
NFKB2 Q00653 2/20 0.43
RELA Q04206 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TP53 P04637 1/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25086307 0.87 HTR2C (0.50) CYP1A2ADRA2AMAOASLC6A2HTR2C
SCHEMBL8982206 0.81 NPC1 (0.49) NPC1RAB9APOLBNFKB1NFKB2
SCHEMBL2246315 0.79 CYP1A2 (0.54) CYP1A2ADRA2AMAOASLC6A2HTR2C
SCHEMBL10759393 0.77 HTR2C (0.49) CYP1A2ADRA2AMAOASLC6A2HTR2C
SCHEMBL8667950 0.76 CA1 (0.38) CYP1A2MAOAGRIA2NPC1RAB9A
SCHEMBL8669883 0.76 CA1 (0.60) CYP1A2ADRA2AMAOASLC6A2HTR2C
SCHEMBL2245582 0.75 BAZ2B (0.64) CYP1A2ADRA2AMAOASLC6A2HTR2C
SCHEMBL1673429 0.75 BAZ2B (0.69) BAZ2BNPC1RAB9AKMT2AMEN1
SCHEMBL2249768 0.75 HTR2C (0.50) CYP1A2ADRA2AMAOASLC6A2HTR2C
SCHEMBL23519580 0.75 HTR2C (0.50) CYP1A2ADRA2AMAOASLC6A2HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5721234-A TREATING CONVULSIONS, ANXIETY, CEREBRAL HYPOXIA/ISCHEMIA, PARKINSON*S DISEASE WARNER-LAMBERT COMPANY (US) 1998-02-24 US disclosed
WO-1998005651-A1 NOVEL GLUTAMATE RECEPTOR ANTAGONISTS: FUSED CYCLOALKYL QUINOXALINEDIONES WARNER-LAMBERT COMPANY (US) 1998-02-12 WO disclosed
WO-1996017832-A1 NOVEL GLUTAMATE RECEPTOR ANTAGONISTS: FUSED CYCLOALKYLQUINOXALINEDIONES WARNER-LAMBERT COMPANY (US) 1996-06-13 WO disclosed